Form 8-K DEXCOM INC For: Sep 14

Go back to Form 8-K DEXCOM INC For: Sep 14

DexCom CEO takes medical leave, COO named interim leader

September 16, 2025 6:05 AM EDT

DexCom Inc. (NASDAQ: DXCM) announced that Chief Executive Officer Kevin R. Sayer will take a temporary medical leave of absence effective September 14, 2025.

The company's board of directors appointed Jacob S. Leach, currently president and chief operating officer, to serve as interim principal executive officer while... More